Artwork
iconShare
 
Manage episode 521318852 series 3327591
Content provided by The Psychedelic Psychiatrist. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Psychedelic Psychiatrist or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

In this episode, Dr. Juan Pablo Galindo breaks down the nuanced differences between psycholytic and psychedelic dosing in Ketamine-Assisted Psychotherapy (KAP)—and why the way we dose matters for therapeutic outcomes.

You’ll learn how lower, talk-friendly doses (psycholytic) support emotional processing in real time, while higher, dissociative doses (psychedelic) offer deeper access to the unconscious. We discuss the therapeutic pros and cons of each approach, and how they can be used intentionally based on clinical goals.

In the second half, we shine a light on a growing concern in ketamine treatment: the overuse of anti-anxiety medications (like benzodiazepines) in IV ketamine clinics when clients feel distressed. Through the lens of Acceptance and Commitment Therapy (ACT), we explore the concept of experiential avoidance—how trying to numb discomfort can actually block healing—and why some of the most difficult moments in therapy are also the most meaningful.

Come visit our website for more information: Innerbloom

  continue reading

28 episodes